glp 1 and gila monster The GLP-1 Story... (a GoggleDocs Podcast) The peptide “exedin-4” was first

Some trials report it as high as 85%

Together, our results indicate that GLP-1 receptor activation enhances glutamate release at PF-PC synapses via the PKA signaling pathway, resulting in enhanced PF-PC synaptic transmission in mice in vitro

Medicaid coverage for GLP-1 medications differs significantly by state, with most programs requiring documented obesity-related conditions or failed prior weight-loss attempts

This brief discusses the current landscape of Medicaid GLP-1 coverage and examines recent trends in Medicaid prescriptions and gross spending on GLP-1s.

Yesterday, the World Health Organization published a guideline in JAMA on the use and indications of #GLP-1 therapies for the management of #obesity in adults

Personalized semaglutide and tirzepatide therapy with in-person consultations, labs, and ongoing care from your provider.